Genome-wide association study using family-based cohorts identifies the WLS and CCDC170/ESR1 loci as associated with bone mineral density by Mullin, Benjamin H. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1186/s12864-016-2481-0
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Mullin, B. H., Walsh, J. P., Zheng, H. F., Brown, S. J., Surdulescu, G. L., Curtis, C., ... Wilson, S. G. (2016).
Genome-wide association study using family-based cohorts identifies the WLS and CCDC170/ESR1 loci as
associated with bone mineral density. BMC Genomics, 17(1), 1-11. [136]. 10.1186/s12864-016-2481-0
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
RESEARCH ARTICLE Open Access
Genome-wide association study using
family-based cohorts identifies the WLS and
CCDC170/ESR1 loci as associated with bone
mineral density
Benjamin H. Mullin1,2*, John P. Walsh1,2, Hou-Feng Zheng3, Suzanne J. Brown1, Gabriela L. Surdulescu4,
Charles Curtis5,6, Gerome Breen5,6, Frank Dudbridge7, J. Brent Richards8,4, Tim D. Spector4 and Scott G. Wilson1,2,4
Abstract
Background: Osteoporosis is a common and debilitating bone disease that is characterised by a low bone mineral
density (BMD), a highly heritable trait. Genome-wide association studies (GWAS) have proven to be very successful
in identifying common genetic variants associated with BMD adjusted for age, gender and weight, however a large
portion of the genetic variance for this trait remains unexplained. There is evidence to suggest significant genetic
correlation between body size traits and BMD. It has also recently been suggested that unintended bias can be
introduced as a result of adjusting a phenotype for a correlated trait. We performed a GWAS meta-analysis in two
populations (total n = 6,696) using BMD data adjusted for only age and gender, in an attempt to identify genetic
variants associated with BMD including those that may have potential pleiotropic effects on BMD and body size traits.
Results: We observed a single variant, rs2566752, associated with spine BMD at the genome-wide significance level in
the meta-analysis (P = 3.36 × 10−09). Logistic regression analysis also revealed an association between rs2566752 and
fracture rate in one of our study cohorts (P = 0.017, n = 5,654). This is an intronic variant located in the wntless Wnt ligand
secretion mediator (WLS) gene (1p31.3), a known BMD locus which encodes an integral component of the Wnt ligand
secretion pathway. Bioinformatics analyses of variants in moderate LD with rs2566752 produced strong evidence for a
regulatory role for the variants rs72670452, rs17130567 and rs1430738. Expression quantitative trait locus (eQTL) analysis
suggested that the variants rs12568456 and rs17130567 are associated with expression of the WLS gene in whole blood,
cerebellum and temporal cortex brain tissue (P = 0.034–1.19 × 10−23). Gene-wide association testing using the VErsatile
Gene-based Association Study 2 (VEGAS2) software revealed associations between the coiled-coil domain containing 170
(CCDC170) gene, located adjacent to the oestrogen receptor 1 (ESR1) gene, and BMD at the spine, femoral neck and total
hip sites (P = 1.0 × 10−06, 2.0 × 10−06 and 2.0 × 10−06 respectively).
Conclusions: Genetic variation at the WLS and CCDC170/ESR1 loci were found to be significantly associated with BMD
adjusted for only age and gender at the genome-wide level in this meta-analysis.
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Background
Osteoporosis is a common and debilitating bone disease
that is characterised by a low bone mineral density
(BMD) and micro architectural deterioration of the bone
tissue, leading to decreased bone strength and an in-
creased risk of fracture [1]. Excess mortality caused by
osteoporotic fracture in women has been estimated at 9
% 1-year post fracture and 24 % 5-years post fracture [2].
The disease is particularly prevalent in postmenopausal
women due to a reduction in oestrogen production, with
subsequent effects on bone as well as intestinal and renal
calcium handling [3, 4]. Environmental factors, such as
dietary calcium intake and exercise, also play a role in the
disease [5, 6].
In addition to the effects of oestrogen and environmen-
tal factors, osteoporosis has a strong genetic component.
BMD, as assessed by dual-energy X-ray absorptiometry
(DXA), is currently the best clinical indicator of fracture
risk and is a highly heritable trait. Twin and family studies
have generated BMD heritability estimates ranging from
0.46–0.92 depending on the anatomical site studied [7, 8],
while individuals with an affected first-degree relative have
a considerably elevated familial relative risk of fragility
fracture of 1.31–4.24 [9, 10]. Various measures of body
size, including height and body mass index (BMI), have
also been shown to have substantial heritable components
[11, 12]. There is evidence to suggest significant genetic
correlation between these traits and BMD [13, 14], and
the existence of genes with pleiotropic effects [15].
Genome-wide association studies (GWAS) have proven
to be very successful in identifying common genetic vari-
ants associated with BMD, with at least 71 loci reported as
associated at a high level of confidence (NHGRI GWAS
Catalogue [16]). However, a large portion of the genetic
variance for BMD remains unexplained and many of the
most significantly associated variants appear to contribute
little to fracture risk [17]. The vast majority of genetic
studies for BMD so far have used weight, age and gender
as covariates to identify genetic variants associated with
BMD independently of these factors. However, this poten-
tially removes some of the influence of genes with pleio-
tropic effects on body size and BMD, and it has recently
been suggested that unintended bias can be introduced as
a result of adjusting a phenotype for a correlated trait [18].
We decided to perform a GWAS meta-analysis using
BMD data adjusted for only age and gender, in an attempt
to identify genetic variants associated with BMD including
those that may have potential mediated pleiotropic effects
on body size traits and bone density (whereby the skeleton
adapts to the extra load by increasing bone density, or ex-
cess fat mass leads to altered secretion of bone active hor-
mones such as oestrogen, leptin and adiponectin [19]),
while also removing the possibility of false positives in-
duced by collider bias.
Methods
Genetics of Osteoporosis (GENOS) cohort
The discovery population used in this study is known as
the Genetics of Osteoporosis (GENOS) cohort. This co-
hort is based on ~1,050 individuals from an extreme dis-
cordant and concordant (EDAC) family-based study of
Northern European/UK ancestry [20–22]. The EDAC
families were selected based on containing a proband aged
25–83 years and having a lumbar spine, femoral neck or
total hip BMD Z-score (defined as the number of standard
deviations above or below the mean BMD of an age and
gender matched control population) of < −1.5. The
GENOS cohort is a powerful resource for detection of loci
relevant to osteopenia and osteoporosis due to the EDAC
study design and enrichment of genetic effects [23]. Clin-
ical data were collected for BMD at the spine, total hip
and femoral neck as well as extensive medical and lifestyle
data. Exclusion criteria were applied and included hyper-
parathyroidism, long-term steroid use (>6 months),
rheumatoid arthritis, anorexia nervosa or surgical oophor-
ectomy. All subjects from the study provided written in-
formed consent and the experimental protocols were
approved by the Sir Charles Gairdner Group Human Re-
search Ethics Committee and the St Thomas’ Hospital Re-
search Ethics Committee.
At a clinic visit, data including age, height, weight, med-
ical, gynaecological, and lifestyle factors were recorded
and a blood sample was collected for DNA extraction.
DXA BMD was assessed (Hologic, Bedford, MA, USA) at
the lumbar spine L1–L4, femoral neck and total hip. BMD
data were adjusted for age and gender prior to analysis by
conversion to BMD Z-scores using the formula: (patient
BMD – mean BMD of age and gender matched control
population)/standard deviation. The NHANES (National
Health and Nutrition Examination Survey) 3 reference
ranges were used to calculate BMD Z-scores at the fem-
oral neck and total hip sites, while the Hologic reference
range was used for the lumbar spine.
TwinsUK cohort
The replication population used in this study is known
as the TwinsUK cohort and is comprised of ~12,000
monozygotic and dizygotic twins unselected for any
particular disease or trait from St Thomas’ UK Adult
Twin Registry (TwinsUK). The cohort is from Northern
European/UK ancestry and has been shown to be rep-
resentative of singleton populations and the UK popu-
lation in general [24]. Medical and lifestyle-factor data
were obtained from questionnaires, with exclusion cri-
teria applied including rheumatoid arthritis, oral steroid
use or surgical oophorectomy. All participants provided
written, informed consent and the research was ap-
proved by the Guy’s and St Thomas’ Hospital Research
Ethics Committee.
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Clinical data for most of the twins were obtained at
several time points for multiple phenotypes including
fracture data (any fracture since 16 years of age) and
DXA BMD (Hologic, Bedford, MA, USA) at the lumbar
spine, femoral neck and total hip sites. DNA for geno-
typing was extracted from whole blood samples ob-
tained for the vast majority of the cohort at the time of
the study visit. BMD measures were adjusted for age
and gender by conversion to BMD Z-scores as de-
scribed above.
Genotyping and imputation
Genotyping was performed for 1,046 individuals in the
GENOS cohort using the Illumina HumanOmniExpress-
12 v1.1 700 K BeadChip, with genotypes called using the
GenCall algorithm (GenomeStudio). Quality control cri-
teria were applied and included gender, ancestry (principal
components analysis (EIGENSTRAT) [25]) and related-
ness (Genome-wide Complex Trait Analysis (GCTA) [26])
checks. Samples with a genotype call rate <99 % were ex-
cluded as were any that were not of Northern European
ancestry or that failed the above checks. Variants with a
call rate <90 % or Hardy-Weinberg P≤ 10−6 were also ex-
cluded. The genotype data was pre-phased using SHA-
PEIT2 [27] before imputation was performed using the
IMPUTE2 software package [28] in conjunction with the
1000 Genomes Project Phase 1 and UK10K Project refer-
ence panels. Imputed variants with an “info” score <0.4
were excluded.
Genotyping in the TwinsUK cohort was completed for
5,654 individuals using the Illumina HumanHap300,
HumanHap610, 1 M-Duo and 1.2 M-Duo arrays, as de-
scribed previously [29, 30]. Imputation was performed
using IMPUTE2 [28] in conjunction with the 1000 Ge-
nomes Project Phase 1 reference panel. Imputed variants
with an info score <0.4 were excluded.
Statistical analysis
Genome-wide association analyses for BMD at the lum-
bar spine, femoral neck and total hip sites was per-
formed in each cohort using GEMMA (Genome-wide
Efficient Mixed Model Association) [31], which con-
trols for familial relatedness within a cohort. Only vari-
ants with a minor allele frequency (MAF) ≥1 % were
included in the analysis. Meta-analysis of the results
from the two cohorts was performed using the GWAMA
(Genome-Wide Association Meta-Analysis) software pack-
age [32] – a fixed effects model was applied, combining es-
timates of the allelic effect size and standard error from
each cohort. Genome-wide significant and suggestive
thresholds were set at 1.17 × 10−08 [33, 34] and 5 × 10−07
respectively. Assuming an additive genetic model, our
combined cohorts (total n = 6,696) have an estimated
88.7 % power to detect a variant with a MAF of 1 % that
accounts for 0.2 % of the trait variance [35]. Any variants
associated with BMD at the genome-wide significance level
were tested for association with fracture rate in the Twin-
sUK cohort using logistic regression adjusted for age, age2,
gender, height and weight (SPSS Statistics 22). Gene-wide
(+/− 10Kb) tests of association with BMD were performed
on the GWAS meta-analysis results using the VErsatile
Gene-based Association Study 2 (VEGAS2) software [36],
which assigns variants to genes and calculates gene-based
empirical association p-values while accounting for the LD
structure within the gene. We have found the +/− 10 Kb
option to be a good balance between incorporating short-
range regulatory variants while maintaining the specificity
of the result for a specific gene, as variants associated with
neighbouring genes can influence the test statistic for a
gene of interest. A genome-wide Bonferroni-corrected sig-
nificance threshold of 2.14 × 10−06 for 23,390 gene tests
was used, with suggestive significance set at 1 × 10−05.
Bioinformatics analysis
Analysis of the linkage disequilibrium (LD) surrounding
variants of interest was performed using LDlink (1000 Ge-
nomes Project Phase 3 EUR population) [37]. Prediction of
histone marks, DNAse hypersensitivity sites and expression
quantitative trait locus (eQTL) associations was performed
using HaploReg v4.0 [38] and genomic evolutionary rate
profiling (GERP) scores were obtained using GWAVA
(Genome Wide Annotation of Variants) [39]. Variants of
interest were also queried using the human osteoblast
eQTL dataset generated by Grundberg et al. [40].
Results
Descriptive statistics for the two cohorts are presented
in Table 1 and quantile-quantile plots generated for the
meta-analysis results are shown in Fig. 1a, b and c (spine
BMD λ = 0.99, femoral neck BMD λ = 0.99, total hip
BMD λ = 1.00). Genome-wide association analysis of the
Table 1 Descriptive statistics for the two cohorts used in the
study
GENOS TwinsUK
Subjects (N) 1,042 5,654
Age, mean (SD) 55.236 (11.658) 47.001 (12.647)
Age (range) 20–83 16–81
Male (%) 1.9 8.3
Spine BMD (g/cm2), mean (SD) 0.878 (0.158) 1.002 (0.143)
Spine BMD Z, mean (SD) −0.446 (1.305) 0.230 (1.267)
Total hip BMD (g/cm2), mean (SD) 0.813 (0.141) 0.941 (0.133)
Total hip BMD Z, mean (SD) −0.319 (1.058) 0.377 (0.992)
Femoral neck BMD (g/cm2), mean (SD) 0.723 (0.139) 0.816 (0.129)
Femoral neck BMD Z, mean (SD) −0.123 (1.147) 0.319 (1.049)
Fracture rate (%) NA 28.3
Mullin et al. BMC Genomics  (2016) 17:136 Page 3 of 11
family-based discovery cohort (GENOS), enriched for in-
dividuals with low BMD, did not yield any genome-wide
significant results. Therefore, we next performed a meta-
analysis of both discovery and replication cohorts.
Spine BMD
We observed a single variant, rs2566752, associated with
spine BMD at the genome-wide significance level in the
meta-analysis (P = 3.36 × 10−09) (Fig. 2a) (Table 2). This
is an intronic variant (C/T) located in the wntless Wnt
ligand secretion mediator (WLS) gene (1p31.3) (Fig. 3),
the less common C allele being associated with an in-
creased spine BMD. This allele was also found to be as-
sociated with a decreased risk of fracture in the
TwinsUK cohort (odds ratio (OR) = 0.86 (95 % confi-
dence interval (CI): 0.77–0.97), P = 0.017).
Five additional loci demonstrated genome-wide sug-
gestive associations (P < 5 × 10−07) with spine BMD, in-
cluding 4q28.1 (FAT4), 6q25.1 (CCDC170/ESR1), 7p22.1
(CCZ1B), 8q13.1 (LINC00251) and 10q22.3 (KCNMA1)
(Table 2).
Femoral neck BMD
No variants were found to be associated with femoral
neck BMD at the genome-wide significance level in
the meta-analysis (Fig. 2b). However, genome-wide
suggestive associations were seen at 6 loci, including
2p12 (CTNNA2), 4p13 (PHOX2B), 6q21 (LINC00222),
10p11.23 (LYZL2), 11q22.1 (CNTN5) and 12q21.33
(LOC728084) (Table 2).
Total hip BMD
No variants were found to be associated with total hip
BMD at the genome-wide significance level in the meta-
analysis (Fig. 2c). However, genome-wide suggestive as-
sociations were seen at 3 loci, including 5q13.1 (LOC1
01928858/PIK3R1), 6q21 (LINC00222) and 9q22.31
(ROR2) (Table 2).
Gene-wide association testing
The VEGAS2 software identified the CCDC170 gene as as-
sociated with spine, femoral neck and total hip BMD at the
genome-wide significance level (P = 1.0 × 10−06, 2.0 × 10−06
and 2.0 × 10−06 respectively). The maximally associated
Fig. 1 Quantile-quantile plots for (a) spine, (b) femoral neck and (c) total hip BMD. Plots display observed p values versus expected p values from
the meta-analysis results
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Fig. 2 Manhattan plots for (a) spine, (b) femoral neck and (c) total hip BMD. Each plot depicts the variants genotyped across the 22 autosomes against
the –log10 P value from the meta-analysis. The blue line represents the suggestive significance threshold of 5 × 10
−07 and the red line represents the
genome-wide significance threshold of 1.17 × 10−08
Table 2 Genome-wide significant and suggestive loci identified in the meta-analysis
GENOS (n = 1,042) TwinsUK (n = 5,654) Meta-analysis (n = 6,696)
Phenotype Locus rsID EA OA EAF Beta P Beta P Beta SE P value Nearby genes
Spine BMD 1p31.3 rs2566752 C T 0.38 0.28 2.3E-5 0.14 1.3E-6 0.16 0.03 3.4E-9 WLS
4q28.1 rs4423886 C T 0.19 −0.17 0.07 −0.22 4.6E-7 −0.21 0.04 2.5E-7 FAT4
6q25.1 rs1038304 G A 0.51 −0.21 8.3E-4 −0.12 1.8E-5 −0.13 0.03 1.8E-7 CCDC170/ESR1
7p22.1 rs188966536 T G 0.02 1.21 1.8E-6 0.51 1.6E-4 0.67 0.12 7.8E-8 CCZ1B
8q13.1 rs76115211 A T 0.07 −0.30 0.04 −0.35 7.9E-7 −0.34 0.07 3.0E-7 LINC00251
10q22.3 rs114936111 A G 0.22 0.29 3.0E-4 0.14 4.1E-5 0.16 0.03 3.6E-7 KCNMA1
Femoral Neck BMD 2p12 rs12998155 C T 0.45 −0.15 6.7E-3 −0.13 8.0E-7 −0.13 0.02 5.4E-8 CTNNA2
4p13 rs17885864 T G 0.03 −0.56 1.6E-3 −0.35 4.2E-6 −0.38 0.07 1.3E-7 PHOX2B
6q21 rs117359272 G C 0.02 0.55 5.8E-3 0.38 1.6E-5 0.41 0.08 4.6E-7 LINC00222
10p11.23 rs73245065 G C 0.02 −0.70 1.0E-4 −0.32 1.4E-5 −0.37 0.07 6.9E-8 LYZL2
11q22.1 rs10893396 C G 0.17 0.17 0.02 0.14 5.9E-6 0.15 0.03 4.1E-7 CNTN5
12q21.33 rs191780267 C T 0.01 0.69 0.02 0.57 4.7E-6 0.59 0.11 4.1E-7 LOC728084
Total Hip BMD 5q13.1 rs78935958 G T 0.06 −0.38 2.8E-3 −0.24 6.1E-6 −0.26 0.05 1.9E-7 LOC101928858/PIK3R1
6q21 rs117359272 G C 0.02 0.56 1.9E-3 0.35 2.9E-5 0.39 0.08 3.6E-7 LINC00222
9q22.31 rs1907805 T C 0.04 0.21 0.18 0.33 2.5E-7 0.31 0.06 2.9E-7 ROR2
Only the maximally associated variant from each locus is shown. EA effect allele, OA other allele, EAF effect allele frequency, SE standard error
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variants for each phenotype were rs1038304 (spine, P =
1.8 × 10−07), rs6557156 (femoral neck, P = 1.23 × 10−5) and
rs62444275 (total hip, P = 2.08 × 10−6) (Fig. 4). No other
genes were found to be associated with any of the BMD
phenotypes at the genome-wide significance level. Suggest-
ive associations were seen for spine BMD with the genes
HOXC5 and HOXC6, which are located in close proximity
on chromosome 12 (P = 1.0 × 10−05 and 1.0 × 10−05 re-
spectively). No other suggestive associations were seen.
Bioinformatics analysis
Analysis of LD in the WLS gene region showed there were
no variants in strong LD (r2 > 0.8) and 10 variants in mod-
erate LD (r2 > 0.5) with rs2566752 (Table 3). All of these
variants were associated with spine BMD P < 5 × 10−05 in
the meta-analysis, apart from rs1430738 (P = 0.002) and
rs36009202 (not present in genotype dataset). Bioinfor-
matics analysis of these variants suggested the presence of
various regulatory features including promoter histone
marks, enhancer histone marks and DNAse hypersensitiv-
ity sites in multiple cell types for the variants rs72670452,
rs17130567 and rs1430738 (Table 3). According to the
HaploReg v4.0 eQTL database [38], which contains eQTL
data for a variety of tissues including results from the pilot
phase of the Genotype-Tissue Expression (GTEx) project
[41], the two variants rs12568456 and rs17130567 were
also associated with expression of the WLS gene in whole
blood, cerebellum and temporal cortex brain tissue (P =
0.034–1.19 × 10−23) [42, 43]. In all three tissues, the less
common allele at these two variants was associated with
increased expression of the WLS gene. The variant
rs72670452 was found to have a GERP score of 3.95
(Table 3), suggesting that the site may be under evolution-
ary constraint. GERP scores are used to quantify nucleo-
tide substitution deficits, which represent “rejected
substitutions” that reflect past purifying selection [44].
Apart from rs36009202 and rs75334237, which were not
present in the dataset, none of the variants in Table 3 were
found to be associated with expression of the WLS gene in
primary human osteoblasts (P = 0.16–0.92) [40].
Analysis of the LD between the maximally associated
variants from the CCDC170 gene for each BMD pheno-
type suggested that the rs6557156 and rs62444275 vari-
ants are in moderate LD (r2 = 0.31), whereas the
rs1038304 variant is in low LD with rs6557156 and
rs62444275 (r2 = 0.05 and 0.02 respectively).
Discussion
We undertook this study to identify genes significantly
associated with BMD adjusted for only age and gender
in order to investigate all genes regulating BMD includ-
ing those with possible pleiotropic effects extending to
aspects of body size. We have demonstrated a genome-
wide significant association between a variant in the
WLS gene (also known as GPR177) and BMD at the
spine in this meta-analysis, as well as an association
with fracture rate in the TwinsUK cohort. The product
of the WLS gene is a chaperone protein that is an inte-
gral component of the Wnt ligand secretion pathway.
There are 19 Wnt proteins in the mammalian genome,
and they represent an evolutionarily conserved family
of secreted signalling molecules. Both the canonical (β-
Fig. 3 Regional association plot for spine BMD from the WLS gene region. Genetic variants within 200 kb of the WLS gene are depicted (x axis)
along with their meta-analysis P value (−log10) from the spine BMD analysis. Variants are colour coded according to their LD (r
2) with the lead
SNP (1000 Genomes Project Nov 2014 EUR population). The recombination rate (blue line) and position of genes, their exons and direction of
transcription is also indicated [69]
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Table 3 Bioinformatics analysis of variants in moderate LD (r2 > 0.5) with rs2566752
Variant Relative
positiona
LD with rs2566752 (r2) GERP score Promoter histone
marks
Enhancer histone
marks
DNAse eQTL results
rs2026749 −3208 0.54 1.26 - - - ND
rs2566752 0 1 −0.317 - - - ND
rs36009202 +112 0.57 0.697 - - - ND
rs75334237
(rs5774922)
+1570 0.53 0 - - - ND
rs2033345 +2060 0.52 0.352 - - - ND
rs2033344 +3701 0.51 −2.5 - 1 tissue - ND
rs57748040 +4196 0.51 −3.48 - 1 tissue - ND
rs12568456 +4789 0.51 −5.1 - 2 tissues - 3 studies
rs72670452 +6143 0.51 3.95 5 tissues 12 tissues 5 tissues ND
rs17130567 +7150 0.51 0.805 4 tissues 18 tissues 12 tissues 3 studies
rs1430738 +7432 0.6 −0.599 2 tissues 17 tissues - ND
aRelative to rs2566752 (hg19); GERP, genomic evolutionary rate profiling; eQTL, expression quantitative trait locus; ND, no data
Fig. 4 Regional association plots for the CCDC170 locus for (a) spine, (b) femoral neck and (c) total hip BMD. Genetic variants within 200 kb of
the CCDC170 gene are depicted (x axis) along with their meta-analysis P value (−log10). Variants are colour coded according to their LD (r
2) with
the lead SNP (1000 Genomes Project Nov 2014 EUR population). The red bars represent the gene-wide region tested and association P value
(−log10). The recombination rate (blue line) and position of genes, their exons and direction of transcription is also indicated [69]
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catenin dependent) and non-canonical (β-catenin inde-
pendent) Wnt signalling pathways have been shown to
play important roles in prenatal and postnatal bone de-
velopment [45]. The product of the WLS gene has been
shown to be required for the activity of virtually all of
the Wnt proteins [46] and Wls-knockout mice display
early embryonic lethality due to impaired body axis for-
mation [47]. Conditional deletion of the Wls gene in
mice has been found to severely impair the develop-
ment of the craniofacial and body skeletons, demon-
strating a role in intramembranous and endochondral
ossification respectively [48].
Genetic variation within the WLS gene has been identi-
fied as associated with BMD in several previous GWAS
[17, 49–51], some of which have observed more than one
independent association signal originating from the locus
[17, 51]. The most recent of these studies, a large meta-
analysis that included a subset of the TwinsUK cohort and
used a combination of whole-genome sequence, whole-
exome sequence and deeply imputed genotype data in its
discovery study (n ≈ 33,000), also identified the rs2566752
single nucleotide polymorphism (SNP) as the maximally
associated variant from the WLS gene region for both
lumbar spine and femoral neck BMD [51]. Consistent
with our findings, this variant was most strongly associ-
ated with BMD at the spine and the C allele was
associated with an increased BMD [51]. Interestingly,
pleiotropic effects on BMD and bone geometric parame-
ters have been previously observed at the WLS locus [52],
although it should be noted that to our knowledge vari-
ation in the WLS gene has not been previously associated
with body size related traits such as height, weight or
BMI. Liu et al. [15] published the results from a bivariate
GWAS for BMI and hip BMD, identifying significant asso-
ciations for two SNPs in the SOX6 gene in males. No sig-
nificant associations were seen for variants in the WLS
locus, however only 380,000 variants were tested genome-
wide and spine BMD was not analysed [15].
It would appear that the associations seen between
rs2566752 and BMD are likely mediated through regula-
tory effects on the WLS gene. The bioinformatics ana-
lysis produced strong evidence for a regulatory role for
the variants rs72670452, rs17130567 and rs1430738,
which are in moderate LD with rs2566752. It should be
noted, however, that there are limitations to using his-
tone modification data when identifying regulatory ele-
ments and further study is required. eQTL data from the
HaploReg v4.0 eQTL database were only available for
variants in the HapMap2 variant set, however this data
suggested that the variants rs12568456 and rs17130567
are significantly associated with expression of the WLS
gene, with the less common allele at each variant associ-
ated with an increase in expression. Judging from the
findings in mice described above, increased expression
of WLS would likely lead to increased BMD, consistent
with the observations for the less common alleles at
these variants in this study. These eQTL findings should
be interpreted with caution, however, as none of the
WLS variants of interest were found to be associated
with expression of the WLS gene in primary human os-
teoblasts derived from 95 donors [40].
Numerous genome-wide suggestive associations were
seen for individual variants in this study, representing a
mix of novel and known bone loci. Some of the more
well-replicated BMD loci include 6q25.1 (CCDC170/
ESR1) [17, 49, 51, 53, 54] and 10q22.3 (KCNMA1) [17,
51]. An interesting novel suggestive association was seen
for spine BMD in the vicinity of the FAT atypical cadherin
4 (FAT4) gene. Mutations in this gene have been shown to
cause Van Maldergem Syndrome 2 [55], which is charac-
terised by intellectual disability, characteristic craniofacial
features and skeletal and limb malformations. Additional
evidence for a role for this gene in bone comes from Fat4-
deficient mice, which are born runted with a curved body
axis, curved tail, abnormal vertebrae morphology and ab-
normal sternum ossification [56, 57]. Another interesting
suggestive association was seen between femoral neck
BMD and a variant in the catenin (cadherin-associated
protein), alpha 2 (CTNNA2) gene, which encodes an α-
catenin that appears to have a role as a cell-cell adhesion
protein by promoting the linking of β-catenin to the cyto-
skeleton and inhibiting its downstream signalling [58].
Genome-wide suggestive associations have been previ-
ously identified between variation in this gene and fore-
arm BMD [59], while mice carrying a mutation affecting
the Ctnna2 gene weigh 25–50 % less than littermate con-
trols [60], which suggests a potential role in growth or
body size regulation.
Gene-wide association testing demonstrated associa-
tions between the coiled-coil domain containing 170
(CCDC170) gene and BMD at the spine, femoral neck and
total hip sites. The fact that this gene was identified as
genome-wide significant by the VEGAS2 software, which
corrects for LD within a gene, is likely indicative of the
presence of multiple independent association signals for
BMD originating from this locus. This phenomenon has
previously been reported at this locus for bone phenotypes
[17, 61, 62] and is supported by the fact that the max-
imally associated variant from the CCDC170 gene region
for each phenotype in this study were not in strong LD
with each other. Gene-wide associations with spine and
femoral neck BMD have been previously reported for this
locus using HapMap Phase II LD data [63]. The
CCDC170 gene encodes a protein with unknown function
and is located adjacent to the ESR1 gene. The ESR1 gene
encodes the oestrogen receptor 1, a DNA-binding tran-
scription factor that regulates the expression of many dif-
ferent genes. Oestrogen has a well-established protective
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effect on the skeleton by slowing the rate of bone re-
modelling and resorption while maintaining the rate of
bone formation [64]. Esr1-knockout mice display de-
creased longitudinal bone growth, increased body
weight [65] and obesity [66]. Loss of function mutations
in the human ESR1 gene result in a variety of skeletal
phenotypes including tall stature, reduced BMD and
cortical thinning, as well as impaired glucose tolerance
and hyperinsulinemia [67, 68]. It is possible that the as-
sociations seen in this study between the CCDC170
gene and BMD reflect the presence of regulatory ele-
ments relevant to the ESR1 gene.
Conclusions
In conclusion, we performed a GWAS for BMD adjusted
for only age and gender using two family-based cohorts.
The size of each cohort was limited in comparison to
current standards for well-powered GWAS, and we were
not able to detect any genome-wide significant loci using
the discovery GENOS cohort alone. By conducting a
meta-analysis of the two family-based cohorts, we con-
firmed that genetic variation at the WLS locus is signifi-
cantly associated with BMD at the genome-wide level.
Bioinformatics and eQTL analyses suggest that the asso-
ciation seen is likely caused by regulatory effects on the
WLS gene. Gene-wide association testing revealed asso-
ciations between the CCDC170 gene and BMD at each
site studied, although these associations may be due to
the presence of regulatory elements relevant to the adja-
cent ESR1 gene.
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